Supernus Pharmaceuticals: Pharmaceutical Company
Risk to Business: 1.702=Severe
Maryland-based Supernus Pharmaceuticals fell prey to a ransomware attack that resulted in a large amount of data being exfiltrated from its networks in mid-November. The Hive ransomware group claimed responsibility for the attack over the Thanksgiving holiday weekend. The group claims to have breached Supernus Pharmaceuticals’ network on November 14 and exfiltrated a total of 1,268,906 files, totaling 1.5 terabytes of data. Supernus Pharmaceuticals says it did not plan to pay a ransom. In a statement, Supernus Pharmaceuticals also disclosed that it did not experience a significant impact on its business, they were quickly able to restore lost data and the company has enacted stronger security measures.
Individual Impact: No consumer PII or financial data exposure was disclosed in this incident as of press time.
Customers Impacted: Unknown
How It Could Affect Your Customers’ Business Companies in the healthcare and pharma sectors have been the favorite targets of ransomware gangs since the start of the global pandemic.
Source: Security Week